Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1998 Jul;36(7):2157–2163. doi: 10.1128/jcm.36.7.2157-2163.1998

Fatal Hormonema dematioides Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis: Criteria for Organism Identification and Review of Other Known Fungal Etiologic Agents

Jong Hee Shin 1, Sang Ku Lee 1, Soon Pal Suh 1, Dong Wook Ryang 1, Nam Ho Kim 1, Michael G Rinaldi 2,3, Deanna A Sutton 3,*
PMCID: PMC105020  PMID: 9650991

Abstract

We report a fatal case a fungal peritonitis caused by the yeast-like dematiaceous mould Hormonema dematioides in a 45-year-old woman. The woman had a 13-year history of insulin-dependent diabetes mellitus and had been on continuous ambulatory peritoneal dialysis for chronic renal failure. H. dematioides was repeatedly isolated from the dialysate culture specimens collected on days 3, 9, 16, and 20 of her hospital stay. Preliminary culture reports on day 7 of the growth of a yeast-like fungus, a probable Candida species, prompted the administration of fluconazole (FLU). Intraperitoneal and intravenous FLU failed to eliminate the mould, and the patient expired on day 21 of her hospital stay. We use this case to present what appears to be the first report of fungal peritonitis due to H. dematioides, to provide laboratorians with criteria for differentiating this organism from the similar mould Aureobasidium pullulans and from various yeast genera, and to provide a review of known fungal taxa inciting peritonitis.


Fungal peritonitis is a serious and potentially life-threatening complication of both intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD). Investigators reviewing significant numbers of CAPD-associated fungal peritonitis episodes cite yeasts, particularly Candida species, as the predominant etiologic agents (10, 12, 13, 20, 29, 37, 38, 50, 52, 53, 54, 58, 61, 63, 65, 66, 68, 73, 78). Filamentous fungi complicating CAPD, although reported less frequently and fewer in number, encompass a wide array of agents, from the classic, systemic pathogens (4, 42, 45) to zygomycetous species (55, 64) and members of numerous moniliaceous (3, 11, 16, 25, 27, 30, 33, 39, 40, 48, 51, 57, 67, 71, 75, 76, 77) and dematiaceous genera (1, 2, 6, 7, 14, 21, 28, 31, 34, 43, 44, 59, 69, 80). See Table 1 for a listing of reported etiologic agents of fungal peritonitis. Filamentous CAPD-associated fungi displaying cream-colored (moniliaceous) colonies and yeast-like synanamorphs may initially be considered Candida or Cryptococcus species. Two such organisms, Hormonema dematioides Lagerberg et Melin [teleomorph, Sydowia polyspora (von Tavel) Müller], the subject of this report, and Aureobasidium pullulans (deBary) Arnaud, an agent previously reported in fungal peritonitis (7, 14), are both initially somewhat mucoid, yeast-like (both macroscopically and microscopically), and hyaline. As they mature, their filamentous nature becomes evident and colonies become dematiaceous, with the production of brown, thick-walled hyphae. McCarthy et al. observed that when tested by conventional yeast identification systems, specifically API 20C yeast identification system strips (bio Mérieux, Marcy l’Etoile, France), A. pullulans usually fails to give a code while H. dematioides may code as Cryptococcus albidus (49). Both organisms may present diagnostic or identification difficulties in the setting of the CAPD-associated fungal peritonitis patient.

TABLE 1.

Reported Etiologic Agents of Fungal Peritonitis

Organism Reference(s)
Alternaria species 6
Alternaria alternata 34
Aspergillus species 30, 51, 57, 75, 76
Aspergillus flavus 8
Aspergillus fumigatus 60, 72, 79
Aspergillus niger 5
Aureobasidium pullulans 7, 14
Bipolaris hawaiiensis 28
Bipolaris spicifera (Drechslera spicifera) 59
Candida species 52, 73
Candida albicans 12, 13, 22, 37, 38, 52, 54, 65, 68, 73, 78, 81
Candida famata 66
Candida (Torulopsis) glabrata 10, 37
Candida guilliermondii 54
Candida krusei 13
Candida lusitaniae 29
Candida norvegensis 58
Candida parapsilosis 13
Candida tropicalis 37
Chrysonilia sitophila (Monilia sitophila) 67
Coccidioides immitis 4
Curvularia species 80
Curvularia lunata 21, 31, 43
Cryptococcus neoformans var. neoformans 46, 47, 82
Exophiala jeanselmei 1, 69
Fusarium species 27, 71
Fusarium moniliforme 71
Fusarium oxysporum 71
Geotrichum species 33
Histoplasma capsulatum var. capsulatum 41, 42, 45
Hormonema dematioides This work
Lecythophora mutabilis 2
Malassezia furfur 36
Malassezia pachydermatis (Pityrosporum pachydermatis) 26
Paecilomyces variotii 11, 16, 48
Penicillium species 25
Rhizopus species 64
Rhizopus microsporus 55
Rhodoturula glutinis 37
Rhodotorula rubra 35, 61
Saccharomyces cerevisiae 53
Trichoderma longibrachiatum 77
Trichoderma viride 40
Trichosporon species 13, 80
Trichosporon cutaneum 9, 20, 50
Verticillium species 3
Wangiella dermatitidis 44

Case report.

A 45-year-old woman on CAPD presented at the emergency room of Chonnam University Hospital on 19 March 1996 with nausea, anorexia, increased body weight (from 56 to 74 kg), abdominal distention, and pitting edema. She had a 13-year history of insulin-dependent diabetes mellitus and had had an arteriovenous shunt inserted in February of 1995. Malfunction of the shunt required switching from hemodialysis to CAPD in April 1995. On 1 March 1996, the patient developed abdominal pain and her dialysate became cloudy. Cefazolin and vancomycin were administered intraperitoneally for 20 days without clinical improvement. Upon admission from the emergency room, the patient’s dialysate cell count was 306/μl, with a predominance of polymorphonuclear neutrophils (70%). The hemoglobin level was 6.6 g/dl, the leukocyte count was 6,700/μl, the blood urea nitrogen level was 12.1 mg/dl, and the serum creatinine level was 5.0 mg/dl. The patient was initially treated with intraperitoneal ceftazidime and imipenem. Fluconazole therapy was started on hospital day 7, following a preliminary culture report indicating the presence of a yeast-like fungus, probably a Candida species, in the dialysate. Dialysate cell counts on day 6 were 2,600/μl, with a predominance of polymorphonuclear neutrophils. On day 8, the patient’s abdominal pain and fever slightly improved, but vasopressive drug and O2 therapies were started due to the occurrence of respiratory insufficiency and hypotension. Dialysate cell counts were 675 and 441/μl on days 9 and 17, respectively. The same yeast-like fungus was cultured from the dialysate on days 3, 9, 16, and 20. Fluconazole was administered intraperitoneally (200 mg/day) for 15 days and intravenously (800 mg/day) for the last 2 days. The catheter tip was removed on day 20. On day 21 the patient began to lose consciousness, appeared to have signs of acute respiratory insufficiency due to hypoxia and septic shock, and expired. Blood cultures for the causative organism remained negative.

Mycology.

All four peritoneal fluid culture specimens collected during the patient’s hospital stay (on days 3, 9, 16, and 20) revealed the same organism. Three of the dialysates were inoculated onto Sabouraud dextrose agar (SDA) (Becton Dickinson, Cockeysville, Md.), prepared in-house (Fig. 1), while one was inoculated into BACTEC 16A and 17A bottles (Becton Dickinson, Towson, Md.). Only the BACTEC 16A bottle (aerobic medium) was positive after 48 h of incubation. Pure growth of cream-colored mucoid colonies was observed on SDA and on the blood agar plate subculture from the BACTEC 16A in 24 to 48 h at 35°C. Growth at 35°C was slow, and a Gram stain of organisms from the colony revealed oval-shaped yeast forms. API 20C yeast identification system strips, tested a total of seven times with identical results, indicated assimilation of glucose, glycerol, 2-keto-gluconate, l-arabinose, d-xylose, adonitol, xylitol, galactose, inositol, sorbitol, cellobiose, maltose, saccharose, trehalose, melibiose, and raffinose, giving a numerical code of 6773277. The API database, which provides a list of species and their probabilities, with a confidence estimate for each identification, indicated the code as an unacceptable profile with no identification. Ancillary testing on cornmeal agar (Difco Laboratories, Detroit, Mich.) by the Dalmau method (17) indicated the presence of hyphae and blastic conidia. Conidia occurred asynchronously from the hyphae as viewed under the coverslip after 72 h of incubation at 25°C (Fig. 2). Prolonged incubation of the isolates for 1, 2, and 3 weeks on SDA revealed their dematiaceous nature (Fig. 3). Subsequent subcultures of the isolate at 25°C were totally brown to black. A 5-day slide culture revealed the presence of moniliaceous blastic conidia being produced from dematiaceous hyphae (Fig. 4).

FIG. 1.

FIG. 1

Slow-growing, cream-colored, mucoid colonies of H. dematioides on SDA (72 h; 35°C).

FIG. 2.

FIG. 2

Basipetal, hyaline blastic conidia of H. dematioides produced asynchronously (one at a time) from hyaline hyphae on cornmeal agar by the Dalmau method (72 h; 25°C). Magnification, ×710.

FIG. 3.

FIG. 3

Macroscopic morphology of H. dematioides on SDA (1 week [A], 2 weeks [B], and 3 weeks [C]; 25°C).

FIG. 4.

FIG. 4

Moniliaceous blastic conidia of H. dematioides being produced from conidiogenous loci (arrows) on dematiaceous hyphae. Magnification, ×280.

Pathogenicity and identifying features.

Fungal peritonitis in patients on CAPD, although significantly less frequent than bacterial peritonitis (3 to 15% versus >80%, respectively), is a well-documented clinical entity (13, 38, 54, 65, 78). Signs and symptoms are essentially the same in both presentations and may include cloudy dialysate effluent, dialysate leukocyte counts greater than 100/mm3, neutrophil counts greater than 50%, abdominal pain, distension, rigidity, nausea and vomiting, diarrhea, and fever. Because of these similarities and the higher incidence of bacterial peritonitis, fungal etiologies may be overlooked and may have contributed, in part, to a delayed antifungal regimen in the case of this patient. She received cefazolin and vancomycin intraperitoneally for 20 days, without improvement, followed by ceftazidine and imipenem intraperitoneally for another 7 days. Not until hospital day 7 (episode day 28), with the report of a Candida species in the dialysate, was fluconazole therapy started. Although the route of infection is not clear, several reports have cited altered host flora due to prior or prolonged use of broad-spectrum antibacterial therapy as a significant risk factor and/or as being associated with the development of fungal peritonitis (13, 38, 54, 65, 78). Fungal cultures taken earlier in the course of this patient’s episode or during the administration of antibacterial agents would have provided direction for more appropriate or additional antifungal therapy.

The recovery of cream-colored, mucoid colonies from the dialysate on hospital day 7 (episode day 28) provided the first evidence of a fungal pathogen. Cream-colored mucoid colonies are consistent with a variety of fungal genera, both yeast-like and filamentous, including Candida, Cryptococcus, Aureobasidium, and Hormonema. In the genera Aureobasidium and Hormonema, cream-colored colonies become brownish to olivaceous black with time, thereby requiring extended incubation for recognition of their dematiaceous nature. The API 20C yeast identification system utilized with these colonies failed to provide an identification, giving an unrecognizable code of 6773277. McCarthy et al. recently reported on 4 of 11 isolates of H. dematioides coding as C. albidus by this method (49). The remaining 7 isolates in their group revealed several different unrecognizable codes, which did not include this isolate’s number, 6773277. Their results reinforce the necessity of performing critical microscopic observations (for blastic conidia, hyphae, pseudohyphae, etc.) and demonstrate the futility of relying solely on binary codes and/or physiologic characteristics for these similar, cream-colored, mucoid taxa. Because the API 20C method failed to provide an identification, the case isolate was subsequently identified by ancillary testing utilizing the Dalmau method for determining the method of conidiogenesis and extended incubation for revealing its dematiaceous affinities. Slide culture preparations normally used for studying methods of conidiogenesis in filamentous fungi are generally less satisfactory than the Dalmau method for visualizing the asynchronous or synchronous development of conidia in Hormonema and Aureobasidium species, respectively.

H. dematioides is an important wood-bluing fungus often isolated from discolored coniferous wood or needles (32). It is also appears to occupy an ecological niche in moist environments, as evidenced by the isolates submitted to the Fungus Testing Laboratory (FTL) at the University of Texas Health Science Center at San Antonio from high-humidity areas. Its pathogenicity in humans has been previously documented as an agent of subcutaneous phaeohyphomycosis of the hands of an immunocompetent host (15). Additional human sites from which the organism has been recovered include cerebrospinal fluid, blood, stool, pleural fluid, a surgical wound, and a knee (FTL isolates [unpublished data]).

Because authors have illustrated H. dematioides under the name of A. pullulans, some cases of infection ascribed to A. pullulans may actually have been caused by misidentified isolates of H. dematioides. Recently Clark et al. described a case of peritonitis caused by A. pullulans in a patient on CAPD (14). Caporale et al. reported A. pullulans as an agent of peritoneal catheter colonization and peritonitis (7). The present case demonstrates that H. dematioides can also cause CAPD-associated peritonitis. The pure growth of the organism from four separate specimens from a patient who had diffuse abdominal pain and turbid dialysates indicates that it was the cause of peritonitis and not a contaminant.

Colonies on SDA at 25°C are white to cream, smooth, and soon covered with a light slimy mass of blastoconidia. Poorly conidiating cultures are olivaceous black with a wooly mycelial mat. The optimum temperature for growth is 24°C, with a daily growth rate of >6 mm; no growth is observed on media containing cycloheximide. Isolates that have been subcultured repeatedly conidiate poorly and tend to grow faster than freshly isolated strains (32). Microscopically, hyphae are septate, hyaline, and initially thin walled and soon become brown and thick walled, with cells wider than they are long. Hyaline, smooth, ellipsoidal blastic conidia (4.5 to 12 μm by 3 to 4.5 μm) are borne asynchronously by percurrent proliferation (each successive conidium growing through the tip of the conidiogenous cell) from mostly intercalary conidiogenous loci on hyaline as well as dematiaceous hyphae (Fig. 4). Older conidia often swell and become brown and are frequently two celled. Endoconidia (conidia formed inside hyphal cells) may be present. The method of conidiogenesis for both A. pullulans and H. dematioides is best studied by the Dalmau method. H. dematioides is differentiated from A. pullulans by asynchronous, basipetal (youngest conidium at the base) conidial formation from both hyaline and dematiaceous hyphae rather than synchronous (all at the same time) conidial formation from only hyaline hyphae. Synchronous conidia appear as a cluster, with each member attached to a separate denticle, while asynchronous conidia appear as a detached cluster around an individual conidiogenous aperture. Also note that several other Hormonema species exist, but all grow <6 mm per day at 24°C. Both H. dematioides and A. pullulans are differentiated from hyaline, mucoid yeasts by the formation of dematiaceous hyphae (Table 2).

TABLE 2.

Differentiation of similar species

Species Macroscopic morphologya Microscopic morphologyb Physiologyc
Comments Reference(s)
Cycloheximide 25°C 35°C 42°C Urease Nitrate Glucose fermentation methyl-α-Glucoside d-Gluconate
Hormonema dematioides Creamy, moist, mucoid, white to cream initially, becoming brown to black Hyphae hyaline and dematiaceous; hyaline, oval-shaped blastic conidia, asynchronous, from hyaline and dematiaceous hyphae; nonbudding + V V V NG NG Cornmeal agar Dalmau plate to determine method of conidiogenesis 18, 19, 32, 62
Aureobasidium pullulans Creamy, moist, white to cream initially, becoming partly brown to black (frequently with a white, radiating fringe at the periphery) Hyphae hyaline and dematiaceous; hyaline, oval-shaped blastic conidia, synchronous, from hyaline hyphae only; nonbudding + V V V G G Cornmeal agar Dalmau plate to determine method of conidiogenesis 18, 19, 32, 62
Candida albicans Cream colored, numerous phenotypes (dry, wrinkled, mucoid) Variably sized, globose to oval budding yeast; pseudohyphae and true hyphae; germ tube positive + + + + + Numerous other yeast species are etiologic agents of CAPD-associated fungal peritonitis 62, 74
Cryptococcus albidus Cream-colored to beige to slight pink, mucoid colonies Large, round budding yeast; no true hyphae or pseudohyphae + W + + Some H. dematioides isolates may code as C. albidus by API 20C 49, 62, 74
Candida parapsilosis Cream-colored, moist Branched pseudohyphae, oval budding yeast + + + A common yeast negative for growth on cycloheximide yeast that could be confused with H. dematioides 74
a

On SDA. 

b

Cornmeal agar, Dalmau method. 

c

Physiology was studied under the following conditions: on medium with cycloheximide; at 25, 35, and 42°C; on Christensen’s urea agar slant (Urease); and by the method of Pincus et al. (62) (Nitrate). Results are reported as follows: −, negative; +, positive; V, variable; W, weak; NG, no growth; and G, growth. 

Therapy.

Fungal peritonitis is associated with significant morbidity and mortality. In the patient this report, intraperitoneal fluconazole (200 mg/day for 15 days) followed by intravenous fluconazole (800 mg/day for 2 days) therapy failed to improve the clinical conditions. Retrospectively, higher empiric doses earlier may have been more efficacious, as judged by data from yeast isolates that exhibit dose-dependent susceptibility to fluconazole and that therefore require maximum dosing regimens (70). Catheter removal, considered a necessary adjunct to antifungal therapy (11, 37, 38, 54, 77), was delayed because there was no other therapeutic option for renal failure in this patient. The patient had severe, frequent hypotension histories associated with the arteriovenous shunt, severe malnutrition, and extensive peritoneal adhesions. Treatment of fungal peritonitis caused by rare fungi such as H. dematioides is complicated by problems in identification, the lack of in vitro antifungal susceptibility data, empiric therapy which may not be appropriate (24), and the reluctance to initiate amphotericin B therapy until a final identification is made. Although standardization of susceptibility testing for filamentous fungi is only commencing (23) and in vivo-in vitro correlations are lacking, a significant number of dematiaceous moulds appear to be susceptible, in vitro, to itraconazole (74). Although the case isolate was not available for testing against antifungal agents, data from the FTL for five similar dematiaceous A. pullulans isolates tested by a modified National Committee for Clinical Laboratory Standards reference method (56) suggest greater in vitro susceptibility to itraconazole. Had the filamentous and dematiaceous nature of the etiologic agent been known earlier, the institution of itraconazole therapy, with or without amphotericin B, may have facilitated defervescence. Several reports cite its use in CAPD-associated fungal peritonitis (12, 22, 28, 39, 67, 77).

Although filamentous fungal organisms in CAPD-associated peritonitis are low in incidence, they are often associated with significant morbidity and/or mortality. As this case emphasizes, consideration of a fungal etiology early in the course of the disease, particularly in patients unresponsive to antibacterial therapy, is crucial. Early recognition and identification of the etiologic agent, coupled with appropriate, aggressive therapy (antifungal therapy and catheter removal, when possible), appear tantamount to a successful outcome. H. dematioides is yet another dematiaceous agent that incites CAPD-associated fungal peritonitis.

REFERENCES

  • 1.Agarwal S, Goodman N L, Malluche H H. Peritonitis due to Exophiala jeanselmei in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1993;21:673–675. doi: 10.1016/s0272-6386(12)80043-6. [DOI] [PubMed] [Google Scholar]
  • 2.Ahmad S, Johnson R J, Hillier S, Shelton W R, Rinaldi M G. Fungal peritonitis caused by Lecythophora mutabilis. J Clin Microbiol. 1985;22:182–186. doi: 10.1128/jcm.22.2.182-186.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Amici G, Grandesso S, Mottola A, Virga G, Teodori T, Maresca M C, Bocci C. Verticillium peritonitis in a patient on peritoneal dialysis. Am J Nephrol. 1994;14:216–219. doi: 10.1159/000168718. [DOI] [PubMed] [Google Scholar]
  • 4.Ampel N M, White J D, Varanasi U R, Larwood T R, Van Wyck D B, Galgiani J N. Coccidioidal peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1988;11:512–514. doi: 10.1016/s0272-6386(88)80088-x. [DOI] [PubMed] [Google Scholar]
  • 5.Bibashi E, Papagianni A, Lelesidis A, Antoniadou R, Papadimitriou M. Peritonitis due to Aspergillus niger in a patient on continuous ambulatory peritoneal dialysis shortly after kidney graft rejection. Nephrol Dial Transplant. 1993;8:185–187. [PubMed] [Google Scholar]
  • 6.Buchanan W E, Quinn M J, Hasbargen J A. Peritoneal colonization with Alternaria: successful treatment with catheter preservation. Periton Dial Int. 1994;14:91–92. [PubMed] [Google Scholar]
  • 7.Caporale N E, Calegari L, Perez D, Gezuele E. Peritoneal catheter colonization and peritonitis with Aureobasidium pullulans. Periton Dial Int. 1996;16:97–98. [PubMed] [Google Scholar]
  • 8.Carpenter J L, Goulks C J, Weiner M H. Peritoneal dialysis complicated by Aspergillus flavus peritonitis: a role for fungal antigen serodiagnosis. Nephron. 1982;32:258–260. doi: 10.1159/000182856. [DOI] [PubMed] [Google Scholar]
  • 9.Carr M E, O’Brien A, Moore D, Keogh J A. Trichosporon cutaneum C.A.P.D. peritonitis. Postgrad Med J. 1987;663:1008. doi: 10.1136/pgmj.63.745.1008. . (Letter.) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cecchin E, De Marchi S, Panarello G, Franceschin A, Chiaradia V, Santini G, Tesio F. Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine. Am J Kidney Dis. 1984;4:280–284. doi: 10.1016/s0272-6386(84)80105-5. [DOI] [PubMed] [Google Scholar]
  • 11.Chan T H, Koehler A, Li P K. Paecilomyces variotii peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1996;27:138–142. doi: 10.1016/s0272-6386(96)90042-6. [DOI] [PubMed] [Google Scholar]
  • 12.Chan T M, Chan C Y, Cheng S W, Lo W K, Lo C Y, Cheng I K. Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant. 1994;9:539–542. doi: 10.1093/ndt/9.5.539. [DOI] [PubMed] [Google Scholar]
  • 13.Cheng I K P, Fang G-X, Chan T-M, Chan P C K, Chan M-K. Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment. Q J Med. 1989;71:407–416. [PubMed] [Google Scholar]
  • 14.Clark E C, Silver S M, Hollick G E, Rinaldi M G. Continuous ambulatory peritoneal dialysis complicated by Aureobasidium pullulans peritonitis. Am J Nephrol. 1995;15:353–355. doi: 10.1159/000168863. [DOI] [PubMed] [Google Scholar]
  • 15.Coldiron B M, Wiley E L, Rinaldi M G. Cutaneous phaeohyphomycosis caused by a rare fungal pathogen, Hormonema dematioides: successful treatment with ketoconazole. J Am Acad Dermatol. 1990;23:363–367. doi: 10.1016/0190-9622(90)70223-5. [DOI] [PubMed] [Google Scholar]
  • 16.Crompton C H, Summerbell R C, Silver M M. Peritonitis with Paecilomyces complicating peritoneal dialysis. Pediatr Infect Dis J. 1991;10:869–871. [PubMed] [Google Scholar]
  • 17.Dalmau L M. Remarques sur la technique mycologique. Ann Parasitol. 1929;7:536–545. [Google Scholar]
  • 18.de Hoog G S, Guarro J. Atlas of clinical fungi. Baarn, The Netherlands: Centraalbureau voor Schimmelcultures; 1995. [Google Scholar]
  • 19.de Hoog G S, Yurlova N A. Conidiogenesis, nutritional physiology and taxonomy of Aureobasidium and Hormonema. Antonie Leeuwenhoek. 1994;65:41–54. doi: 10.1007/BF00878278. [DOI] [PubMed] [Google Scholar]
  • 20.De Saedeleer B, Sennesael J, Van der Niepen P, Verbeelen D. Intraperitoneal fluconazole therapy for Trichosporon cutaneum peritonitis in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1994;9:1658–1659. [PubMed] [Google Scholar]
  • 21.DeVault G A, Jr, Brown S T, 3rd, King J W, Fowler M, Oberle A. Tenckhoff catheter obstruction resulting from invasion by Curvularia lunata in the absence of peritonitis. Am J Kidney Dis. 1985;6:124–127. doi: 10.1016/s0272-6386(85)80153-0. [DOI] [PubMed] [Google Scholar]
  • 22.Edwards R, Birrell L N, Finch R G. In vitro evaluation of antifungal agents in the treatment of yeast peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD) Chemioterapia. 1987;6:3–7. [PubMed] [Google Scholar]
  • 23.Espinel-Ingroff A, Dawson K, Pfaller M, Anaissie E, Breslin B, Dixon D, Fothergill A, Paetznick V, Peter J, Rinaldi M, Walsh T. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother. 1995;39:314–319. doi: 10.1128/aac.39.2.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fabris, A., M. V. Pellanda, C. Gardin, A. Contestabile, and R. Bolzonella. 1993. Pharmacokinetics of antifungal agents. Periton. Dial. Int. 13(Suppl.)2:S380–S382. [PubMed]
  • 25.Fahhoum J, Gelfand M S. Peritonitis due to Penicillium sp. in a patient receiving continuous ambulatory peritoneal dialysis. South Med J. 1996;89:87–88. doi: 10.1097/00007611-199601000-00017. [DOI] [PubMed] [Google Scholar]
  • 26.Fine A, Churchill D, Guult H, Furdy P. Pityrosporum pachydermatis peritonitis in a CAPD patient on long term intraperitoneal antibiotics. Periton Dial Bull. 1983;3:108–109. [Google Scholar]
  • 27.Flynn J T, Meislich D, Kaiser B A, Polinsky M S, Baluarte H J. Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature. Periton Dial Int. 1996;16:52–57. [PubMed] [Google Scholar]
  • 28.Gadallah M F, White R, el-Shahawy M A, Abreo F, Oberle A, Work J. Peritoneal dialysis complicated by Bipolaris hawaiiensis peritonitis: successful therapy with catheter removal and oral itraconazole without the use of amphotericin B. Am J Nephrol. 1995;15:348–352. doi: 10.1159/000168862. [DOI] [PubMed] [Google Scholar]
  • 29.Garcia-Martos P, Diaz J, Castano M, Perez M, Marin P. Peritonitis caused by Candida lusitaniae in a patient on continuous ambulatory peritoneal dialysis (CAPD) Clin Nephrol. 1991;36:50. . (Letter.) [PubMed] [Google Scholar]
  • 30.Geiss H K. Peritoneal aspergillosis—pitfalls in the diagnosis of a rare disease. Nephrol Dial Transplant. 1995;10:1124–1125. [PubMed] [Google Scholar]
  • 31.Guarner J, Del Rio C, Williams P, McGowan J E., Jr Fungal peritonitis caused by Curvularia lunata in a patient undergoing peritoneal dialysis. Am J Med Sci. 1989;298:320–323. doi: 10.1097/00000441-198911000-00008. [DOI] [PubMed] [Google Scholar]
  • 32.Hermanides-Nijhof E J. Aureobasidium and allied genera. Stud Mycol. 1977;14:144–176. [Google Scholar]
  • 33.Hernandez Jaras J, Martinez-Martinez L, Gallego J L, Fernandez Fernandez J, Botella J. Geotrichum sp. as an agent of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) Clin Nephrol. 1987;28:210. . (Letter.) [PubMed] [Google Scholar]
  • 34.Horisberger J-D, Bille J, Waters J-P. Fungal eosinophilic peritonitis due to Alternaria in a patient on continuous ambulatory peritoneal dialysis. Periton Dial Bull. 1984;4:255–256. [Google Scholar]
  • 35.Isenberg E S, Alpert B E, Weiss R A, Mittman N, Soeiro R. Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Am J Med. 1983;7755:349–352. doi: 10.1016/0002-9343(83)91216-0. [DOI] [PubMed] [Google Scholar]
  • 36.Johnson A S, Bailey E, Wright P A, Solomon L. Malassezia furfur: a possible cause of culture-negative CAPD peritonitis. Periton Dial Int. 1996;16:187–188. [PubMed] [Google Scholar]
  • 37.Johnson R J, Ramsey P G, Gallagher N, Ahmad S. Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis. Am J Nephrol. 1985;5:169–175. doi: 10.1159/000166928. [DOI] [PubMed] [Google Scholar]
  • 38.Kerr C M, Perfect J R, Craven P C, Jorgensen J H, Drutz D J, Shelburne J D, Gallis H A, Gutman R A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med. 1983;99:334–337. doi: 10.7326/0003-4819-99-3-334. [DOI] [PubMed] [Google Scholar]
  • 39.Kitiyakara C, Sakulsaengprapha A, Domrongkitchaiporm S. The role of surgery and itraconazole in Aspergillus peritonitis in CAPD. Nephrol Dial Transplant. 1966;11:1498. . (Letter.) [PubMed] [Google Scholar]
  • 40.Loepky C B, Sprouse R F, Carlson J V, Everett E D. Trichoderma viride peritonitis. South Med J. 1983;76:798–799. doi: 10.1097/00007611-198306000-00029. [DOI] [PubMed] [Google Scholar]
  • 41.Lopez J O, Alves S H, Benevenga J P, Rosa A C. The second case of peritonitis due to Histoplasma capsulatum during continuous ambulatory peritoneal dialysis in Brazil. Mycoses. 1994;37:161–163. doi: 10.1111/j.1439-0507.1994.tb00294.x. [DOI] [PubMed] [Google Scholar]
  • 42.Lopez J O, Alves S H, Benevenga J P, Regio O R, Calil A. Histoplasma capsulatum peritonitis associated with continuous ambulatory peritoneal dialysis. Mycopathologia. 1993;122:101–102. doi: 10.1007/BF01103606. [DOI] [PubMed] [Google Scholar]
  • 43.Lopez J O, Alves S H, Benevenga J P, Brauner F B, Castro M S, Melchiors E. Curvularia lunata peritonitis complicating peritoneal dialysis. Mycopathologia. 1994;127:65–67. doi: 10.1007/BF01103059. [DOI] [PubMed] [Google Scholar]
  • 44.Lye W C. Peritonitis due to Wangiella dermatitidis. Periton Dial Int. 1993;13:319–320. [PubMed] [Google Scholar]
  • 45.Ma K W. Disseminated histoplasmosis in dialysis patients. Clin Nephrol. 1985;24:155–177. [PubMed] [Google Scholar]
  • 46.Mabee C L, Mabee S W, Kirkpatrick R B, Koletar S L. Cirrhosis: a risk factor for cryptococcal peritonitis. Am J Gastroenterol. 1995;90:2042–2045. [PubMed] [Google Scholar]
  • 47.Mansoor G A, Ornt D B. Cryptococcal peritonitis in peritoneal dialysis patients: a case report. Clin Nephrol. 1994;41:230–232. [PubMed] [Google Scholar]
  • 48.Marzec A, Heron L G, Pritchard R C, Butcher R H, Powell H R, Disney A P, Tosolini F A. Paecilomyces variotii in peritoneal dialysate. J Clin Microbiol. 1993;31:2392–2395. doi: 10.1128/jcm.31.9.2392-2395.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.McCarthy D I, Fothergill A W, Sutton D A, Rinaldi M G. Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. Washington, D.C: American Society for Microbiology; 1997. Possible misidentification of Hormonema dematioides which code as Cryptococcus albidus on API 20C, abstr. F88; p. 275. [Google Scholar]
  • 50.Melez K A, Cherry J, Sanchez C, Ettinger R B, Walsh T J. Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole. Pediatr Infect Dis J. 1995;14:1110–1113. [PubMed] [Google Scholar]
  • 51.Miles A M, Barth R H. Aspergillus peritonitis: therapy, survival, and return to peritoneal dialysis. Am J Kidney Dis. 1995;26:80–83. doi: 10.1016/0272-6386(95)90158-2. [DOI] [PubMed] [Google Scholar]
  • 52.Montenegro J, Aguirre R, Gonzales O, Martinez I, Saracho R. Fluconazole treatment of Candida peritonitis with delayed removal of the peritoneal dialysis catheter. Clin Nephrol. 1995;44:60–63. [PubMed] [Google Scholar]
  • 53.Mydlik M, Tkacova E, Szovenyiova K, Mizla P, Derzsiova K. Saccharomyces cerevisiae peritonitis complicating CAPD. Periton Dial Int. 1996;16:188. [PubMed] [Google Scholar]
  • 54.Nagappan R, Collins J F, Lee W T. Fungal peritonitis in continuous ambulatory peritoneal dialysis: the Auckland experience. Am J Kidney Dis. 1992;20:492–496. doi: 10.1016/s0272-6386(12)70262-7. [DOI] [PubMed] [Google Scholar]
  • 55.Nakamura M, Weil W B, Jr, Kaufman D B. Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine. Pediatr Nephrol. 1989;3:80–82. doi: 10.1007/BF00859631. [DOI] [PubMed] [Google Scholar]
  • 56.National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Wayne, Pa: National Committee for Clinical Laboratory Standards; 1997. [Google Scholar]
  • 57.Nguyen M H, Muder P R. Aspergillus peritonitis in a continuous ambulatory peritoneal dialysis patient. Case report and review of the literature. Diagn Microbiol Infect Dis. 1994;20:99–103. doi: 10.1016/0732-8893(94)90099-x. [DOI] [PubMed] [Google Scholar]
  • 58.Nielsen H, Stenderup J, Bruun B, Ladefoged J. Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1990;28:1664–1665. doi: 10.1128/jcm.28.7.1664-1665.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.O’Sullivan F X, Stuewe B R, Lynch J M, Brandsberg J W, Wiegman T B, Patak R V, Barnes W G, Hodges G R. Peritonitis due to Drechslera spicifera complicating continuous ambulatory peritoneal dialysis. Ann Intern Med. 1981;94:213–214. doi: 10.7326/0003-4819-94-2-213. [DOI] [PubMed] [Google Scholar]
  • 60.Park S B, Kim K H, Joo I, Kim H C. Scanning electron microscopy studies of peritoneal catheter in CAPD peritonitis due to Aspergillus fumigatus. Periton Dial Int. 1996;16:81–83. [PubMed] [Google Scholar]
  • 61.Pennington J C, 3rd, Hauer K, Miller W. Rhodotorula rubra peritonitis in an HIV+ patient on CAPD. Del Med J. 1995;67:184. [PubMed] [Google Scholar]
  • 62.Pincus D, Kemna M, Salkin I. Modification of potassium nitrate assimilation test for identification of clinically important yeasts. J Clin Microbiol. 1988;26:1300–1302. doi: 10.1128/jcm.26.2.366-368.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Piraino B, Hamburger R J. Complicated multiorganism peritonitis. Periton Dial Int. 1995;15:394–400. [PubMed] [Google Scholar]
  • 64.Polo J R, Luno J, Menarguez C, Gallego E, Robles R, Hernandez P. Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1989;13:237–239. doi: 10.1016/s0272-6386(89)80058-7. [DOI] [PubMed] [Google Scholar]
  • 65.Powel D, San Luis E, Calvin S, McDaid R, Potter D. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis. Am J Dis Child. 1985;139:29–32. doi: 10.1001/archpedi.1985.02140030031021. [DOI] [PubMed] [Google Scholar]
  • 66.Quindos G, Cabrera F, Arilla M C, Burgos A, Ortiz-Vigon R, Canon J L, Ponton J. Fatal Candida famata peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis who was treated with fluconazole. Clin Infect Dis. 1994;18:658–660. doi: 10.1093/clinids/18.4.658. [DOI] [PubMed] [Google Scholar]
  • 67.Radix A E, Bieluch V M, Graeber C W. Peritonitis caused by Monilia sitophila in a patient undergoing peritoneal dialysis. Int J Artif Organs. 1996;19:218–220. [PubMed] [Google Scholar]
  • 68.Rault R. Candida peritonitis complicating chronic peritoneal dialysis: a report of five cases and review of the literature. Am J Kidney Dis. 1983;2:544–547. doi: 10.1016/s0272-6386(83)80097-3. [DOI] [PubMed] [Google Scholar]
  • 69.Remon C, de la Calle I J, Vallejo Carrion F, Perez-Ramos S, Fernandez Ruiz E. Exophiala jeanselmei peritonitis in a patient on CAPD. Periton Dial Int. 1996;16:536–538. [PubMed] [Google Scholar]
  • 70.Rex J H, Pfaller M A, Galgiani J N, Bartlett M S, Espinel-Ingroff A, Ghannoum M A, Lancaster M, Odds F C, Rinaldi M G, Walsh T J, Barry A L Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis. 1997;24:235–247. doi: 10.1093/clinids/24.2.235. [DOI] [PubMed] [Google Scholar]
  • 71.Rippon J W, Larson R A, Rosenthal D M, Clayman J. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species; three cases and review of the literature. Mycopathologia. 1988;101:105–111. doi: 10.1007/BF00452895. [DOI] [PubMed] [Google Scholar]
  • 72.Sartin J S, Wilhelm M P, Keating M R, Batts K, Krom R A. A case of Aspergillus fumigatus peritonitis complicating liver transplantation. Eur J Clin Microbiol Infect Dis. 1994;13:25–28. doi: 10.1007/BF02026119. [DOI] [PubMed] [Google Scholar]
  • 73.Struijk D G, Boeschoten E W, Krediet R T, Kuijper E J. Fluconazole in Candida peritonitis in CAPD: an alternative proposal. Nephrol Dial Transplant. 1995;10:426. [PubMed] [Google Scholar]
  • 74.Sutton D A, Fothergill A W, Rinaldi M G. Guide to clinically significant fungi. Baltimore, Md: Williams & Wilkins; 1998. [Google Scholar]
  • 75.Tanis B C, Verburgh C A, van’t Wout J W, van der Pijl J W. Aspergillus peritonitis in peritoneal dialysis: case report and a review of the literature. Nephrol Dial Transplant. 1995;10:1240–1243. [PubMed] [Google Scholar]
  • 76.Tanis B C, Verburgh C A, van der Pijl J W, van’t Wout J W. Aspergillus peritonitis in peritoneal dialysis. Nephrol Dial Transplant. 1996;11:752. doi: 10.1093/oxfordjournals.ndt.a027385. . (Letter.) [DOI] [PubMed] [Google Scholar]
  • 77.Tanis B C, Van der Pijl H, van Ogtrop M L, Kibbelaar R E, Chang P C. Fatal fungal peritonitis by Trichoderma longibrachiatum complicating peritoneal dialysis. Nephrol Dial Transplant. 1995;10:114–116. [PubMed] [Google Scholar]
  • 78.Tapson J S, Mansy H, Freeman R, Wilkinson R. The high morbidity of CAPD fungal peritonitis—description of 10 cases and review of treatment strategies. Q J Med. 1986;61:1047–1053. [PubMed] [Google Scholar]
  • 79.Tsoufakis G E, Iatrou C E, Petropoulou M, Zerbala S C, Vayiakou H S, Polychronopoulou C A, Ziroyanis P N. Aspergillus fumigatus peritonitis in a patient on CAPD. Periton Dial Int. 1995;15:184–185. [PubMed] [Google Scholar]
  • 80.Ujhelyi M R, Raasch R H, van der Horst C M, Mattern W D. Treatment of peritonitis due to Curvularia and Trichosporon with amphotericin B. Rev Infect Dis. 1990;112:621–627. doi: 10.1093/clinids/12.4.621. [DOI] [PubMed] [Google Scholar]
  • 81.Vincent F, Bensousan T A, Leclercq B. Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: use of high dosages of fluconazole or solely removal of the catheter? Nephrol Dial Transplant. 1995;10:141–142. [PubMed] [Google Scholar]
  • 82.Yinnon A M, Solages A, Treanor J J. Cryptococcal peritonitis: report of a case developing during continuous ambulatory peritoneal dialysis and review of the literature. Clin Infect Dis. 1993;17:736–741. doi: 10.1093/clinids/17.4.736. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES